A Discussion with 2 Authors of the Family Heart Foundation Research Paper on PCSK9 Inhibitors - FULL

Поделиться
HTML-код
  • Опубликовано: 26 окт 2024

Комментарии • 6

  • @pmg1x
    @pmg1x 7 месяцев назад

    Thank you for getting this important information out there. And for the Family Heart Foundation for fighting this uphill battle. I have been on a PCSK9 inhibitor for years. It has lowered my LDL, triglycerides, and raised my HDL to acceptable levels. I never thought it would be possible! Best wishes for success of this important fight!

  • @stevel5437
    @stevel5437 8 месяцев назад

    Another great video, thank you.

  • @dwtubeyou
    @dwtubeyou 8 месяцев назад

    Thank you for this important video! You are fighting the good fight with reluctant insurers. Perhaps inclisiran is a good PCSK9i step forward, at least for traditional Medicare patients, since it is covered under Part B vs Part D?

  • @saicheongko8198
    @saicheongko8198 6 месяцев назад

    Underutilizing PCSK9Inhibiter - its exorbitant cost is a major gactor.